کد مقاله کد نشریه سال انتشار مقاله انگلیسی نسخه تمام متن
5906802 1159987 2013 6 صفحه PDF دانلود رایگان
عنوان انگلیسی مقاله ISI
Molecular confirmation of founder mutation c.-167A>G in Tunisian patients with PMLD disease
موضوعات مرتبط
علوم زیستی و بیوفناوری بیوشیمی، ژنتیک و زیست شناسی مولکولی ژنتیک
پیش نمایش صفحه اول مقاله
Molecular confirmation of founder mutation c.-167A>G in Tunisian patients with PMLD disease
چکیده انگلیسی

Pelizaeus Merzbacher disease and Pelizaeus Merzbacher like disease (PMLD) are hypomyelinating leucodystrophies of the central nervous system (CNS) with a very similar phenotype. PMD is an X-linked recessive condition caused by mutations, deletion duplication or triplication of the proteolipid protein 1 gene (PLP1). However, PMLD is a recessive autosomal hypomyelinating leukodystrophy caused by mutations of the GJC2 gene. In this study, we analyzed 5 patients belonging to 4 Tunisian families. Direct sequencing of GJC2 gene in all probands showed the same homozygous founder mutation c.-167A>G localized in the promoter region. We also generated two microsatellite markers GJC2 195GT and GJC2 76AC closed to the GJC2 gene to confirm the presence of a founder effect for this mutation. Haplotype study showed that the c.-167A>G promoter mutation occurred in a specific founder haplotype in Tunisian population. The identification of this founder mutation has important implications towards genetic counseling in relatives of these families and the antenatal diagnosis.

► PMLD was characterized by disorder in myelin formation. ► We investigated mutation in GJC2 coding exon and promoter region. ► We identified c.-167A>G mutation in GJC2 promoter region. ► We generated two new extragenic microsatellite markers. ► We confirmed a founder effect of c.-167A>G mutation.

ناشر
Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: Gene - Volume 513, Issue 2, 25 January 2013, Pages 233-238
نویسندگان
, , , , , , , , ,